MEDLEY PHARMS FDA Approval ANDA 210319

ANDA 210319

MEDLEY PHARMS

FDA Drug Application

Application #210319

Application Sponsors

ANDA 210319MEDLEY PHARMS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL2MG/ML0MEMANTINE HYDROCHLORIDEMEMANTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-08-31STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

MEDLEY PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210319
            [companyName] => MEDLEY PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"MEMANTINE HYDROCHLORIDE","activeIngredients":"MEMANTINE HYDROCHLORIDE","strength":"2MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/31\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-31
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.